Metraipolis › archive › dc_07db2289a339
Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective… — Europe PMC PMID:41634892
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41634892
- DOI
- 10.1186/s40780-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:01:09.805Z
- SHA-256 of the archived text
6d35289d1bf75ad183f7010daa0731c93468b9c5a916b2449e68574433254e99- Stable URL of this page
https://metraipolis.com/documento/dc_07db2289a339
How to cite
Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective… — Europe PMC PMID:41634892 — Europe PMC (en), https://europepmc.org/article/MED/41634892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07db2289a339 (Metraipolis archive dc_07db2289a339, sha256 6d35289d1bf75ad183f7010daa0731c93468b9c5a916b2449e68574433254e99)
BibTeX
@misc{dc07db2289a339,
title = {Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective… — Europe PMC PMID:41634892},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41634892},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07db2289a339; sha256 6d35289d1bf75ad183f7010daa0731c93468b9c5a916b2449e68574433254e99},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41634892. Agents can read the archived copy with the MCP tool read_document.